VVOS vs XLK
Vivos Therapeutics Inc (VVOS) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported VVOS revenue for 2026-06-30 was $10.3M. Net income was -$13.2M. VVOS currently screens at market cap $7.1M.
XLK does not have a complete income-statement cache yet.
VVOS currently screens at market cap $7.1M. XLK currently screens at market cap $0.
Not investment advice. Open the VVOS and XLK stock pages for the full models.
Not investment advice.